Geptanolimab Biosimilar (PDCD1 / PD-1 / CD279 Reference Antibody)
Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1) . Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer.
Product Specifications
Target
Geptanolimab Biosimilar (Anti-PDCD1 / PD-1 / CD279 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cancer Biology; Immunology & Inflammation; Cell Biology
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
251206 50 µL
RNPEPL1 (Arginyl Aminopeptidase (Aminopeptidase B) -like 1, FLJ10806, FLJ26675, MGC99544)
Sign In for Pricing
View Details 
